Cross-organ multi-omics profiling of microbiome and metabolome along the gut-liver axis in MASH model mice induced by western diet and MC4R knockout
Gut Pathogens
Researcher Yamamoto from Pharmacology Business Unit, will deliver …
Researcher Hashikami from Pharmacology Business Unit , will …
Proteros and Axcelead DDP Enter Strategic Collaboration to …
Dr. Hirano from the Screening Business Unit, will …
Dr. Takakuwa from the Pharmacology Business Unit, will …
Dr. Murakami from the Pharmacology Business Unit, will …